No news available

Accelerate your drug discovery and biomarker projects with our high sensitive and multiplex immunoassay technologies

BioSIMS specializes in the multiplex quantification of proteins, in tissues and body fluids.

Our strengths lie in the development of highly sensitive technologies to:


Gain insights into disease mechanisms
Study drug resistances

Identify new targets
Research disease and predictive biomarkers

Demonstrate the relevance of in vitro or animal models
Screen compound mode of action
Quantify pharmaco-dynamic biomarkers

BioSIMS Protein Microarrays